INFEX Therapeutics is a startup based in All, most recent round Series A, 1 tracked investor.
Based in All, INFEX Therapeutics is a startup. Its most recent tracked round is Series A. Brouky records 1 investor associated with the company.
Infex Therapeutics (InfexTx) acquires, develops and licenses innovative anti-infective drugs to treat pandemic and drug-resistant infections. The company is based at Alderley Park in the North West of England and is advancing clinical programmes (eg. RESP-X/INFEX702) into Phase IIa while raising development funding.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.